Adial Pharmaceuticals Files 8-K Report

Ticker: ADIL · Form: 8-K · Filed: Jul 16, 2025 · CIK: 1513525

Adial Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyAdial Pharmaceuticals, Inc. (ADIL)
Form Type8-K
Filed DateJul 16, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 8-K, other-events

TL;DR

ADIAL filed an 8-K for 'Other Events' on 7/14/25 - details TBD.

AI Summary

On July 14, 2025, Adial Pharmaceuticals, Inc. filed an 8-K report. The filing indicates an 'Other Events' item, but the specific details of this event are not elaborated upon in the provided text. The company is incorporated in Delaware and its principal executive offices are located in Glen Allen, VA.

Why It Matters

This filing signals a material event has occurred for Adial Pharmaceuticals, requiring disclosure to investors. The nature of the event is currently unspecified.

Risk Assessment

Risk Level: medium — The filing is an 8-K for 'Other Events,' which can cover a wide range of material developments, but the lack of specific detail in the provided text introduces uncertainty.

Key Numbers

  • 001-38323 — Commission File Number (Identifies the company's SEC filing history.)

Key Players & Entities

  • ADIAL PHARMACEUTICALS, INC. (company) — Registrant
  • July 14, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • Glen Allen, VA (location) — Address of principal executive offices
  • 001-38323 (identifier) — Commission File Number

FAQ

What specific event is reported under 'Other Events' in this 8-K filing?

The provided text for the 8-K filing states 'Other Events' as the item information but does not specify the nature of the event.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on July 14, 2025.

Where are Adial Pharmaceuticals, Inc.'s principal executive offices located?

Adial Pharmaceuticals, Inc.'s principal executive offices are located at 4870 Sadler Road, Ste 300, Glen Allen, VA 23060.

In which state is Adial Pharmaceuticals, Inc. incorporated?

Adial Pharmaceuticals, Inc. is incorporated in Delaware.

What is the Commission File Number for Adial Pharmaceuticals, Inc.?

The Commission File Number for Adial Pharmaceuticals, Inc. is 001-38323.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 16, 2025 regarding ADIAL PHARMACEUTICALS, INC. (ADIL).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.